Pituitary adenylate cyclase-activating polypeptide causes rapid Ca2+ release from intracellular stores and long lasting Ca2+ influx mediated by Na+ influx-dependent membrane depolarization in bovine adrenal chromaffin cells.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 8603609)

Published in Endocrinology on March 01, 1996

Authors

K Tanaka1, I Shibuya, T Nagamoto, H Yamashita, T Kanno

Author Affiliations

1: Department of Biomedical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.

Articles citing this

PACAP regulates immediate catecholamine release from adrenal chromaffin cells in an activity-dependent manner through a protein kinase C-dependent pathway. J Neurochem (2009) 1.04

Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse? J Mol Neurosci (2012) 0.97

Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J Clin Invest (1998) 0.96

The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion. J Biol Chem (2007) 0.95

Pituitary adenylate cyclase-activating polypeptide may function as a neuromodulator in guinea-pig adrenal medulla. J Physiol (2000) 0.87

Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents. J Physiol (2003) 0.87

Pituitary adenylate cyclase-activating peptide (PACAP) recruits low voltage-activated T-type calcium influx under acute sympathetic stimulation in mouse adrenal chromaffin cells. J Biol Chem (2011) 0.85

PAC1hop receptor activation facilitates catecholamine secretion selectively through 2-APB-sensitive Ca(2+) channels in PC12 cells. Cell Signal (2010) 0.85

Meta-analysis of microarray-derived data from PACAP-deficient adrenal gland in vivo and PACAP-treated chromaffin cells identifies distinct classes of PACAP-regulated genes. Peptides (2007) 0.80

Serotonin and Serotonin Transporters in the Adrenal Medulla: A Potential Hub for Modulation of the Sympathetic Stress Response. ACS Chem Neurosci (2017) 0.76

pathFinder: a static network analysis tool for pharmacological analysis of signal transduction pathways. Sci Signal (2008) 0.76

Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels. Front Endocrinol (Lausanne) (2013) 0.76

Articles by these authors

Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature (1997) 6.73

Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A (1993) 4.99

Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest (1998) 4.94

2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. J Biochem (1997) 4.69

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology (1998) 4.29

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell (1993) 3.57

Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem (1994) 3.49

Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenal chromaffin cells: an analysis employing techniques of tissue culture. J Physiol (1967) 3.39

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell (1993) 3.35

Characterization of type I receptors for transforming growth factor-beta and activin. Science (1994) 2.94

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun (1998) 2.66

Influence of the ionic environment on the membrane potential of adrenal chromaffin cells and on the depolarizing effect of acetylcholine. J Physiol (1967) 2.48

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem (1999) 2.44

Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis (1998) 2.40

Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A (1999) 2.39

Cerebral arteriovenous malformations: factors influencing the surgical difficulty and outcome. Neurosurgery (1991) 2.36

Amnestic people with Alzheimer's disease who remembered the Kobe earthquake. Br J Psychiatry (1998) 2.26

Exocytosis (secretory granule extrusion) induced by injection of calcium into mast cells. Can J Physiol Pharmacol (1973) 2.24

Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature (1995) 2.20

Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A (1995) 2.19

Subcutaneous release of trigger thumb and fingers in 210 fingers. J Hand Surg Br (1990) 2.05

Regulation of glucagon release in mouse -cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol (2000) 2.05

Voltage-gated and resting membrane currents recorded from B-cells in intact mouse pancreatic islets. J Physiol (1999) 2.01

Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ Res (1998) 1.94

Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood (1999) 1.79

OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol (2009) 1.73

Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) (2006) 1.73

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology (1990) 1.72

Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem (1996) 1.72

New jet irrigation bipolar system. Neurosurgery (1996) 1.70

Calcium-dependent amylase release and electrophysiological measurements in cells of the pancreas. J Physiol (1972) 1.69

UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell (2005) 1.68

Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke (1982) 1.67

Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg (2001) 1.65

Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells (2001) 1.65

BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology (1991) 1.63

Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem (2000) 1.61

The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J (1993) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Activation of Ca(2+)-dependent K(+) channels contributes to rhythmic firing of action potentials in mouse pancreatic beta cells. J Gen Physiol (1999) 1.59

Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Paraplegia (1989) 1.55

Impact of congenital narrowing of the bulbar urethra (Cobb's collar) and its transurethral incision in children. Eur Urol (1999) 1.54

High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J (2001) 1.53

Phosphorylation-dependent power output of transgenic flies: an integrated study. Biophys J (1997) 1.50

Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene (2012) 1.50

Pupillary block after pupillary capture of an AcrySof intraocular lens. J Cataract Refract Surg (1998) 1.50

Viability of an Escherichia coli pgsA null mutant lacking detectable phosphatidylglycerol and cardiolipin. J Bacteriol (2000) 1.50

Supernumerary head of biceps brachii and branching pattern of the musculocutaneus nerve in Japanese. Surg Radiol Anat (1992) 1.50

Patch-clamp characterisation of somatostatin-secreting -cells in intact mouse pancreatic islets. J Physiol (2000) 1.49

Neuroprotective mechanism of bromocriptine. Lancet (1995) 1.48

Cerebral hemodynamics in patients with chronic obstructive carotid disease by rCBF, rCBV, and rCBV/rCBF ratio using SPECT. J Nucl Med (1990) 1.45

Application of three-dimensional CT angiography (3D-CTA) to cerebral aneurysms. Surg Neurol (1999) 1.44

Disruption of the Escherichia coli cls gene responsible for cardiolipin synthesis. J Bacteriol (1988) 1.43

Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients. Pharmacopsychiatry (2002) 1.43

Extremely prolonged vecuronium clearance in a brain death case. Anesthesiology (2001) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Profiling the adult human liver transcriptome: analysis by cDNA array hybridization. J Hepatol (2001) 1.41

Alteration of phospholipid composition by combined defects in phosphatidylserine and cardiolipin synthases and physiological consequences in Escherichia coli. J Bacteriol (1985) 1.41

Vitamin K concentrations in the maternal milk of Japanese women. Acta Paediatr (2004) 1.40

Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol (1989) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Isolated prolonged retrograde amnesia. Eur Neurol (1992) 1.39

Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg (1998) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia (2010) 1.33

Studies of antidromically identified neurosecretory cells of the hypothalamus by intracellular and extracellular recordings. J Physiol (1972) 1.33

Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J Endocrinol (2000) 1.31

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem (1999) 1.28

A new potent excitant, quisqualic acid: effects on crayfish neuromuscular junction. Neuropharmacology (1974) 1.27

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

A pitfall in the interhemispheric translamina terminalis approach for the removal of a craniopharyngioma. Significance of preserving draining veins. Part II. Experimental study. Surg Neurol (1989) 1.27

Active increase in cardiolipin synthesis in the stationary growth phase and its physiological significance in Escherichia coli. FEBS Lett (1993) 1.26

Phasically firing neurons in the supraoptic nucleus of the rat hypothalamus: immunocytochemical and electrophysiological studies. Neurosci Lett (1983) 1.25

Incidence of stroke in Shibata, Japan: 1976-1978. Stroke (1982) 1.24

The effect of amethocaine on acetylcholine-induced depolarization and catecholamine secretion in the adrenal chromaffin cell. Br J Pharmacol Chemother (1967) 1.24

Hereditary deficiency of lactate dehydrogenase M-subunit. Clin Chim Acta (1980) 1.23

A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol Cell Biol (1997) 1.22

The electrogenic sodium pump in the hyperpolarizing and secretory effects of pancreozymin in the pancreatic acinar cell. J Physiol (1975) 1.22

Angiographic classification of aneurysms of the horizontal segment of the anterior cerebral artery. Surg Neurol (1985) 1.22

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol (2002) 1.21

Can 3D-CTA surpass DSA in diagnosis of cerebral aneurysm? Acta Neurochir (Wien) (2001) 1.21

Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma). Cancer (1985) 1.21

Membrane phospholipid synthesis and phenotypic correlation of an Escherichia coli pss mutant. J Bacteriol (1977) 1.21

Scar remodeling and transmural deformation after infarction in the pig. Circulation (1994) 1.21

Drastic alteration of cycloheximide sensitivity by substitution of one amino acid in the L41 ribosomal protein of yeasts. J Bacteriol (1992) 1.21

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol (1992) 1.19

Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients. Liver Int (2007) 1.19

Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett (2001) 1.19

Endogenous viral sequences and their potential contribution to heritable virus resistance in plants. EMBO J (2002) 1.19

Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta (1994) 1.19

Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res (2002) 1.19

Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport (2000) 1.18

Current management and long-term prognosis of hepatolithiasis. Arch Surg (1995) 1.18

Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry (1997) 1.17

Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct Funct (1999) 1.17

Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology (1999) 1.16